Aimmune Therapeutics
Get Full AccessDescription
- Aimmune Therapeutics is a clinical-stage biopharmaceutical company developing desensitization treatments to protect people with food allergies from the life-threatening consequences of accidental exposures to their allergens. We are currently conducting a Phase 3 study of our lead product, AR101 for the treatment of peanut allergy.
-
Headquarters:8000 Marina Boulevard Suite 300, Brisbane, California, United States
More -
Phone Number: +1 650-614-5220
-
Website: https://www.aimmune.com
-
Employees:362
-
Revenue:$250 - 500M
-
Legal Name:Aimmune Therapeutics
-
Aimmune Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
View Employees
Frequently Asked Questions regarding Aimmune Therapeutics
-
Where are Aimmune Therapeutics's Headquarters?
Aimmune Therapeutics's Headquarters are in 8000 Marina Boulevard Suite 300,Brisbane,California,United States
-
What is Aimmune Therapeutics's phone number?
Aimmune Therapeutics's phone number is +1 650-614-5220
-
What is Aimmune Therapeutics's official website?
Aimmune Therapeutics's official website is https://www.aimmune.com
-
What is Aimmune Therapeutics's Revenue?
Aimmune Therapeutics's revenue is $250 - 500M
-
What is Aimmune Therapeutics's NAICS code?
Aimmune Therapeutics's NAICS code is 325412
-
How many employees are working in Aimmune Therapeutics
Aimmune Therapeutics has 362 employees
-
What is Aimmune Therapeutics's Industry?
Aimmune Therapeutics is in the industry of Biotechnology
-
Who is Aimmune Therapeutics's CEO?
Aimmune Therapeutics's CEO is Andrew Oxtoby

